| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/31/2003 | US20030144881 Method and program for identifying multiple diluent solutions for use in drug delivery with a healthcare system |
| 07/31/2003 | US20030144878 System and method for providing multiple units of measure |
| 07/31/2003 | US20030144639 A multilayer having a therapeutic drug fixed on it for drug delivery |
| 07/31/2003 | US20030144356 Formulation |
| 07/31/2003 | US20030144352 Antimuscarinic aerosol |
| 07/31/2003 | US20030144335 Nitroimidazole compound for allergic conjunctivitis or allergic rhinitis |
| 07/31/2003 | US20030144324 Comprising paroxetine hydrochloride anhydrous, povidone, copovidone as binder, and a hydrochloric acid free/non-hygroscopic filler, prepared by wet granulation; antidepressant, anxiety disorders, sexual disorders |
| 07/31/2003 | US20030144309 Inhibitors of Src and other protein kinases |
| 07/31/2003 | US20030144306 A liquid oral composition comprising a proton pump inhibitor, e,g, omeprazole, lansoprazole,and a buffer; can also contain a parietal cell activator; acid resistance; side effect reduction; kits; drug delivery; Zollinger-Ellison syndrome |
| 07/31/2003 | US20030144299 Method of treating depression with delta receptor agonist compounds |
| 07/31/2003 | US20030144247 Obtained by reacting polyalkylene glycol or a reactive derivative, a phospholipid and a drug with each other to form covalent bonds to form a delivery substance |
| 07/31/2003 | US20030144244 Stable compositions of S-adenosyl-l-methionine with dextran |
| 07/31/2003 | US20030144230 Covalent coupled of nucleic acids, peptides or proteins to active material for enhancing transfection efficiency; potentiation |
| 07/31/2003 | US20030143949 Filters for combined radiotelephone/GPS terminals |
| 07/31/2003 | US20030143739 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 07/31/2003 | US20030143702 Vesicular monoamine transporter gene therapy in parkinson's disease |
| 07/31/2003 | US20030143312 Baking adjuvant |
| 07/31/2003 | US20030143281 Composition of restricted cancer cells which produce cancer cell proliferation suppressive materials, and uses thereof |
| 07/31/2003 | US20030143280 For therapy of dry eye |
| 07/31/2003 | US20030143279 Method for preparing microparticles having a selected polymer molecular weight |
| 07/31/2003 | US20030143278 Vaginal delivery of drugs |
| 07/31/2003 | US20030143277 Drug delivery system |
| 07/31/2003 | US20030143276 For hormone therapy |
| 07/31/2003 | US20030143274 For drug delivery |
| 07/31/2003 | US20030143273 Soluble form osmotic dose delivery system |
| 07/31/2003 | US20030143272 Pharmaceutical tablet and process for making thereof |
| 07/31/2003 | US20030143271 For therapy and prophylaxis of cyclooxygenase-2 mediated disorder and for providing cardioprotection |
| 07/31/2003 | US20030143270 Extended release composition containing Tramadol |
| 07/31/2003 | US20030143269 Tamper-resistant oral opioid agonist formulations |
| 07/31/2003 | US20030143268 Three-dimensional printing process; uniaxially compressing the dosage form |
| 07/31/2003 | US20030143267 Sugar-modified liposome and products comprising the liposome |
| 07/31/2003 | US20030143266 Combining cationic lipid with polyethyleneglycol derivative to produce homogeneous micellar lipids; combining with biologically active molecule to form micellar complexes |
| 07/31/2003 | US20030143265 Administering riboflavin or derivatives |
| 07/31/2003 | US20030143264 Topical anesthetic-antiseptic patch |
| 07/31/2003 | US20030143262 Hygiene tissue |
| 07/31/2003 | US20030143259 Topical treatment or prevention of ocular infections |
| 07/31/2003 | US20030143257 For controlled release of the drug |
| 07/31/2003 | US20030143250 Pharmaceutical compositions comprising cyclosporins |
| 07/31/2003 | US20030143248 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 07/31/2003 | US20030143197 Administering to the animal omega interferon (IFN) at a dosage and activity for the disease state treated sufficient to induce a therapeutic response in the animal |
| 07/31/2003 | US20030143195 Use of histamine as a drug delivery enhancing compound for use in transmucosal or transdermal delivery |
| 07/31/2003 | US20030143189 Therapy for topical diseases |
| 07/31/2003 | US20030143184 Shelf life of longer than three years in a sterilized container, stability of longer than three days in infusion fluid, has minimal side effects and shows improved bioavailability |
| 07/31/2003 | US20030143166 Aqueous dispersion of water-insoluble organic UV filter substances |
| 07/31/2003 | US20030143165 Regularly applying a topical formulation to the skin of patient, formulation containing a pharmaceutically effective amount of a non- steroidal anti-inflammatory drug |
| 07/31/2003 | US20030143163 For therapy of respiratory disorders; aerosol formulations of use for the administration of medicaments by inhalation |
| 07/31/2003 | US20030143162 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics |
| 07/31/2003 | US20030142901 Switchable surfaces |
| 07/31/2003 | US20030141368 System and method for obtaining information from a bar code for use with a healthcare system |
| 07/31/2003 | US20030141301 High temperature high pressure capsule for processing materials in supercritical fluids |
| 07/31/2003 | US20030140959 Photovoltaic cell interconnection |
| 07/31/2003 | US20030140929 Infusion therapy bar coding system and method |
| 07/31/2003 | US20030140921 Methods and systems for operating an aerosol generator |
| 07/31/2003 | US20030140920 Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma |
| 07/31/2003 | US20030140863 Delivering substances to invertebrate organisms |
| 07/31/2003 | DE29824938U1 Pharmaceutical preparation comprising clodronate |
| 07/31/2003 | DE10160888C1 Wirkstoffhaltige Unterwäsche und das Verfahren zur Herstellung und/oder Regenerierung derselben Active ingredient-containing underwear and the process for preparation and / or regeneration thereof |
| 07/31/2003 | CA2511257A1 Stimulation of bone growth and cartilage formation with thrombin peptide derivatives |
| 07/31/2003 | CA2511223A1 Thrombin derived peptides for promoting cardiac tissue repair |
| 07/31/2003 | CA2484146A1 Electrostatic application of powder material to solid dosage forms |
| 07/31/2003 | CA2476984A1 Lactoferrin as an agent for enhancing action of an opioid |
| 07/31/2003 | CA2475340A1 Therapeutic decorative object |
| 07/31/2003 | CA2474292A1 Sustained release pharmaceutical composition |
| 07/31/2003 | CA2473927A1 Methods and compositions for treating polycystic ovary syndrome |
| 07/31/2003 | CA2473884A1 Method of treatment of a patient requiring analgesia |
| 07/31/2003 | CA2473841A1 Film-forming compositions and methods |
| 07/31/2003 | CA2473748A1 Novel targeted compositions for diagnostic and therapeutic use |
| 07/31/2003 | CA2473719A1 Liposome-encapsulated opioid analgesics prepared by rehydration/dehydration method |
| 07/31/2003 | CA2473717A1 Dna dosage forms |
| 07/31/2003 | CA2473697A1 Compositions for pulmonary administration |
| 07/31/2003 | CA2473679A1 Dna dosage forms |
| 07/31/2003 | CA2473677A1 Formulation for the administration of medicinal substances |
| 07/31/2003 | CA2473490A1 Peptide-carrying bodies for immune response |
| 07/31/2003 | CA2473395A1 Phospholipid bodies and use thereof in medical treatment |
| 07/31/2003 | CA2473283A1 Process for preparing aqueous-alcoholic solution and products based thereon |
| 07/31/2003 | CA2473059A1 Apparatus and process for preparing crystalline particles |
| 07/31/2003 | CA2473040A1 A weight management system for obese animals |
| 07/31/2003 | CA2472775A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 07/31/2003 | CA2472588A1 Oral administration of interferon-tau |
| 07/31/2003 | CA2472467A1 Improved determination of gas solubility, entrained gas content, and true liquid density in manufacturing processes |
| 07/31/2003 | CA2472186A1 Combination il-2/anti-her2 antibody therapy for cancers characterized by overexpression of the her2 receptor protein |
| 07/31/2003 | CA2471740A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/31/2003 | CA2469721A1 Stabilized formulations of adenovirus |
| 07/31/2003 | CA2452545A1 West nile vaccine comprising live attenuated, inactivated or killed whole or subunit west nile virus |
| 07/31/2003 | CA2441796A1 Solid orally-dispersible pharmaceutical formulation |
| 07/31/2003 | CA2434256A1 Methods for inactivation of pathogens in biological materials |
| 07/30/2003 | EP1331003A1 Extended release formulation containing venlafaxine |
| 07/30/2003 | EP1331002A2 Oil-free pharmaceutical compositions containing cyclosporin A |
| 07/30/2003 | EP1331001A1 Novel dispersible and soluble galenic paracetamol formulation, method for its preparation and its applications |
| 07/30/2003 | EP1330520A2 Therapeutic oligonucleotides of reduced toxicity |
| 07/30/2003 | EP1330465A2 Derivatised carbohydrates and their use in solid delivery systems |
| 07/30/2003 | EP1330441A2 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
| 07/30/2003 | EP1330439A1 (7-(3-carboxyphenyl)-4-chloroisoquinolin-1-yl)guanidine |
| 07/30/2003 | EP1330428A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and the alkanoyl l-carnitines with taurine chloride and glycine chloride |
| 07/30/2003 | EP1330293A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 07/30/2003 | EP1330276A1 Implantable medical device for delivering a liquid |
| 07/30/2003 | EP1330270A2 Sustained release device for treating conditions of the joint |
| 07/30/2003 | EP1330268A1 Targeted therapeutic agents |
| 07/30/2003 | EP1330266A1 Method for making very fine particles consisting of a principle inserted in a host molecule |
| 07/30/2003 | EP1330265A1 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |